Novartis Investigative Site
Targovishte 7700
0 studies enrolling now · 1 studies all time
What they study most
Spondylitis, Ankylosing
Studies at this site
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis
— Completed